Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 3
1(16.7%)
6Total
N/A(5)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT01441856Not ApplicableCompleted

The ORANGE II PLUS - Trial: Open Versus Laparoscopic Hemihepatectomy

Role: collaborator

NCT04053998Completed

Benchmarking Outcomes in Pancreatic Surgery - WhippleBenchmarks.Org

Role: collaborator

NCT04290416Not ApplicableUnknown

Human Single Neuron Recordings in Epilepsy Patients

Role: collaborator

NCT02949505Not ApplicableCompleted

Impact of Exercise Therapy on Functional Capacity in Patients Listed for Liver Transplantation

Role: collaborator

NCT03632681Not ApplicableCompleted

Effect of Intranasal Insulin on Cognitive Processes and Appetite

Role: collaborator

NCT02637362Not ApplicableUnknown

Optimal Analgesia for Forefoot Surgery

Role: lead

NCT00150696Phase 3Completed

Risedronate for the Prevention of Osteoporosis in People With Spinal Cord Injury.

Role: collaborator

All 7 trials loaded